With QCI Precision Insights, you can reduce test turnaround time by 85-90%—regardless of panel size.
Powered by a world-class team of molecular biologists and oncologists, QCI Precision Insights delivers concise clinical evidence for each biomarker in the context of the cancer sub-type, listing information on the mutation’s molecular characteristics, roles in disease, and therapeutic, prognostic, and diagnostic implications.
You receive a ready to use expert-assembled report content with detailed assessments of variants, written summaries of evidence with references, treatments, and geographically matched clinical trials.